“A Lot of Times,We Feel Disposable. Do you Understand? Like We Could Just Be Thrown Away.” Characterizing Consumer Perspectives on Substance Use Treatment Gaps

Abstract

Background

Participatory models can facilitate the design of substance use treatment programs that are best equipped to support their end users, yet many structural barriers limit people who use drugs from effectively engaging in decision-making roles. This study explored how well substance treatment programs are meeting the needs of a group of people who inject drugs (PWID), highlighting a persisting misalignment between their perceived treatment needs and actual treatment experiences.

Methods

22 PWID completed one or two in-depth interviews between April 2023 and March 2024. Eligibility included having injected drugs in the past six months and reporting one or more lifetime experiences of trauma. A thematic analysis was conducted to synthesize participants’ descriptions of treatment gaps and the adverse impacts of these unmet needs.

Results

Participants reported a range of unmet substance use treatment needs, including (1) a lack of integrated mental health care; (2) insufficient incentive systems, punitive forms of accountability, and overly short programs; (3) persisting stigmatization from treatment professionals; and (4) limited recovery supports, including facing incarceration over treatment, unsafe housing spaces, and no opportunities for life skills development or employment access. These treatment gaps were associated with adverse substance use and recovery outcomes.

Conclusions

These findings demonstrate that many treatment programs continue to operate without meeting the perceived needs of their end users, suggesting the importance of scaling up consumer engagement models in the substance use treatment landscape. Participants highlight many opportunities for programmatic and policy-level changes that would enable treatment programs to better align with their needs. These include expanding the mental health workforce, adopting fair-chance hiring practices, and prioritizing system-wide efforts to reduce stigma toward people who use drugs. Finally, they reinforce the importance of adopting a non-punitive approach to substance use that treats opioid use disorder as a chronic condition rather than a crime.

Keywords

qualitative research stigmatization treatment systems injecting drug use

Get full access to this article

View all access options for this article.

References

Armstrong

Allen

(2017). Behind the luxury: Turmoil and shoddy care inside five-star addiction treatment centers. STAT. https://www.statnews.com/2017/08/25/recovery-centers-of-america-addiction/

Beetham

Saloner

Gaye

Wakeman

S. E.

Frank

R. G.

Barnett

M. L.

(2021). Admission practices and cost of care for opioid use disorder at residential addiction treatment programs in the US. Health Affairs, 40(2), 317–325. https://doi.org/10.1377/hlthaff.2020.00378

Bielenberg

Swisher

Lembke

Haug

N. A.

(2021). A systematic review of stigma interventions for providers who treat patients with substance use disorders. Journal of Substance Abuse Treatment, 131, 108486. https://doi.org/10.1016/j.jsat.2021.108486

Brener

Resnick

Ellard

Treloar

Bryant

(2009). Exploring the role of consumer participation in drug treatment. Drug and Alcohol Dependence, 105(1), 172–175. https://doi.org/10.1016/j.drugalcdep.2009.06.016

Brooklyn

J. R.

Sigmon

S. C.

(2017). Vermont hub-and-spoke model of care for opioid use disorder: Development. Implementation, and Impact. Journal of Addiction Medicine, 11(4), 286–292. https://doi.org/10.1097/ADM.0000000000000310

Brousselle

Lamothe

Sylvain

Foro

Perreault

(2010). Integrating services for patients with mental and substance use disorders: What matters? Health Care Management Review, 35(3), 212–223. https://doi.org/10.1097/HMR.0b013e3181d5b11c

Cook

J. A.

Leff

H. S.

Blyler

C. R.

Gold

P. B.

Goldberg

R. W.

Mueser

K. T.

Toprac

M. G.

McFarlane

W. R.

Shafer

M. S.

Blankertz

L. E.

Dudek

Razzano

L. A.

Grey

D. D.

Burke-Miller

(2005a). Results of a multisite randomized trial of supported employment interventions for individuals with severe mental illness. Archives of General Psychiatry, 62(5), 505–512. https://doi.org/10.1001/archpsyc.62.5.505

Cook

J. A.

Lehman

A. F.

Drake

McFarlane

W. R.

Gold

P. B.

Leff

H. S.

Blyler

Toprac

M. G.

Razzano

L. A.

Burke-Miller

J. K.

Blankertz

Shafer

Pickett-Schenk

S. A.

Grey

D. D.

(2005b). Integration of psychiatric and vocational services: A multisite randomized, controlled trial of supported employment. American Journal of Psychiatry, 162(10), 1948–1956. https://doi.org/10.1176/appi.ajp.162.10.1948

Dennis

Scott

(2007). Managing addiction as a chronic condition. Addiction Science & Clinical Practice, 4(1), 45–55. https://doi.org/10.1151/ascp074145

10.

Dutra

Stathopoulou

Basden

S. L.

Leyro

T. M.

Powers

M. B.

Otto

M. W.

(2008). A meta-analytic review of psychosocial interventions for substance use disorders. American Journal of Psychiatry, 165(2), 179–187. https://doi.org/10.1176/appi.ajp.2007.06111851

11.

Edwards

E. R.

Barnes

Govindarajulu

Geraci

Tsai

(2021). Mental health and substance use patterns associated with lifetime suicide attempt, incarceration, and homelessness: A latent class analysis of a nationally representative sample of U.S. veterans. Psychological Services, 18(4), 619–631. https://doi.org/10.1037/ser0000488

12.

European Union Drugs Agency. (2023). Spotlight on… Comorbid substance use and mental health problemse. https://www.euda.europa.eu/spotlights/comorbid-substance-use-and-mental-health-problems_en#:∼:text=The%20presence%20of%20these%20comorbid,and%20the%20substance%20use%20disorders

13.

Families Against Mandatory Minimums. (2017). Recent State-Level Reforms to Mandatory Minimums Laws. http://famm.org/wpcontent/uploads/2017/05/Recent-State-Reforms-May-2017.pdf

14.

Federal Recovery-Ready Workplace Interagency Workgroup. (2023). Recovery Ready Workplace Toolkit: Guidance and Resources for Private and Public Sector Employers . https://www.dol.gov/sites/dolgov/files/ETA/RRW-hub/pdfs/RRW_Toolkit_508_FINAL_v5%2011.8.23.pdf

15.

Federal Register. (2023). Fair Chance To Compete for Jobs. Office of Personnel Management. https://www.federalregister.gov/documents/2023/09/01/2023-18242/fairchance-to-compete-for-jobs#h-3

16.

French

M. T.

Popovici

Tapsell

(2008). The economic costs of substance abuse treatment: Updated estimates and cost bands for program assessment and reimbursement. Journal of Substance Abuse Treatment, 35(4), 462–469. https://doi.org/10.1016/j.jsat.2007.12.008

17.

Frone

Osborne

Chosewood

Howard

(2022). Workplace Supported Recovery: New NIOSH Research Addresses an Evolving Crisis. Centers for Disease Control and Prevention. https://blogs.cdc.gov/niosh-science-blog/2022/11/30/workplace-supported-recovery/

18.

Goodhew

Stein-Parbury

Dawson

(2018). Consumer participation in drug treatment: A systematic review. Drugs and Alcohol Today, 19(2), 97–112. https://doi.org/10.1108/DAT-05-2018-0023

19.

Hoffman

K. A.

Ponce Terashima

McCarty

(2019). Opioid use disorder and treatment: Challenges and opportunities. BMC Health Services Research, 19(1), 884. https://doi.org/10.1186/s12913-019-4751-4

20.

Jhanjee

(2014). Evidence based psychosocial interventions in substance use. Indian Journal of Psychological Medicine, 36(2), 112–118. https://doi.org/10.4103/0253-7176.130960

21.

Jones

C. M.

McCance-Katz

E. F.

(2019). Co-occurring substance use and mental disorders among adults with opioid use disorder. Drug and Alcohol Dependence, 197, 78–82. https://doi.org/10.1016/j.drugalcdep.2018.12.030

22.

King

(2011). Service user involvement in methadone maintenance programmes: The ‘philosophy, the ideal and the reality’. Drugs: Education, Prevention and Policy, 18(4), 276–284. https://doi.org/10.3109/09687637.2010.495098

23.

Larney

Tran

L. T.

Leung

Santo

Jr Santomauro

Hickman

Peacock

Stockings

Degenhardt

(2020). All-cause and cause-specific mortality among people using extramedical opioids: A systematic review and meta-analysis. JAMA Psychiatry, 77(5), 493–502. https://doi.org/10.1001/jamapsychiatry.2019.4170

24.

Livingston

J. D.

(2020). Structural Stigma in Health-Care Contexts for People with Mental Health and Substance Use Issues: A Literature Review. Mental Health Commission of Canada. https://doi.org/10.13140/RG.2.2.21168.17929

25.

Lurie

(2019). “Mom, when they look at me, they see dollar signs”: How rehab recruiters are luring recovering opioid addicts into a deadly cycle. Mother Jones. https://www.motherjones.com/crime-justice/2019/02/opioid-epidemic-rehab-recruiters/

26.

Lynch

A. C.

Weber

A. N.

Hedden

Sabbagh

Arndt

Acion

(2021). Three-month outcomes from a patient-centered program to treat opioid use disorder in Iowa, USA. Substance Abuse Treatment, Prevention, and Policy, 16(1), 8. https://doi.org/10.1186/s13011-021-00342-5

27.

Madras

B. K.

Ahmad

N. J.

Wen

Sharfstein

J. S.

(2020). Improving access to evidence-based medical treatment for opioid use disorder: Strategies to address key barriers within the treatment system. NAM Perspectives, 10.31478/202004b, https://doi.org/10.31478/202004b

28.

Marshall

Goldberg

R. W.

Braude

Dougherty

R. H.

Daniels

A. S.

Ghose

S. S.

George

Delphin-Rittmon

M. E.

(2014). Supported employment: Assessing the evidence. Psychiatric Services (Washington, D.C.), 65(1), 16–23. https://doi.org/10.1176/appi.ps.201300262

29.

Martinelli

T. F.

Nagelhout

G. E.

Bellaert

Best

Vanderplasschen

van de Mheen

(2020). Comparing three stages of addiction recovery: Long-term recovery and its relation to housing problems, crime, occupation situation, and substance use. Drugs: Education, Prevention and Policy, 27(5), 387–396. https://doi.org/10.1080/09687637.2020.1779182

30.

Mathematica. (2022). Implementation and Impacts of the Certified Community Behavioral Health Clinic Demonstration: Findings from the National Evaluation. Office of the Assistant Secretary for Planning and Evaluation (ASPE) at the U.S. Department of Health & Human Services. https://aspe.hhs.gov/sites/default/files/documents/60f121a777ee63b20008e43ad45518bf/ccbhc-implementation-impacts-findings.pdf

31.

Mathematica and Eagle Technologies. (2021). Availability of Employment Services for People with Opioid and Other Substance Use Disorders. https://www.mathematica.org/publications/availability-of-employment-services-for-people-with-opioid-and-other-substance-use-disorders

32.

Mathers

B. M.

Degenhardt

Bucello

Lemon

Wiessing

Hickman

(2013). Mortality among people who inject drugs: A systematic review and meta-analysis. Bulletin of the World Health Organization, 91(2), 102–123. https://doi.org/10.2471/BLT.12.108282

33.

McCarty

Priest

K. C.

Korthuis

P. T.

(2018). Treatment and prevention of opioid use disorder: Challenges and opportunities. Annual Review of Public Health, 39, 525–541. https://doi.org/10.1146/annurev-publhealth-040617-013526

34.

Mumba

M. N.

Davis

Smith

N. L.

Evans

Castillo

(2022). Effects of unemployment on opioid use treatment trajectories: Impact of the COVID-19 pandemic. Journal of Addictions Nursing, 33(3), 168–171. https://doi.org/10.1097/JAN.0000000000000480

35.

National Center for Drug Abuse Statistics. (2025). Drug Abuse Statistics. https://drugabusestatistics.org/

36.

National Council for Mental Wellbeing. (2020). CCBHC Success Center. https://www.thenationalcouncil.org/wp-content/uploads/2021/12/What_is_a_CCBHC_UPDATED_8-5-20.pdf

37.

National Institute of Justice. (2011). Program Profile: Drug Treatment Alternative to Prison (DTAP). Crime Solutions. https://crimesolutions.ojp.gov/ratedprograms/89#7-0

38.

National Research Council. (2014). The Growth of Incarceration in the United States: Exploring Causes and Consequences. The National Academies Press.

39.

Padwa

Guerrero

E. G.

Braslow

J. T.

Fenwick

K. M.

(2015). Barriers to serving clients with co-occurring disorders in a transformed mental health system. Psychiatric Services, 66(5), 547–550. https://doi.org/10.1176/appi.ps.201400190

40.

Paquette

C. E.

Syvertsen

J. L.

Pollini

R. A.

(2018). Stigma at every turn: Health services experiences among people who inject drugs. International Journal of Drug Policy, 57, 1040–1110. https://doi.org/10.1016/j.drugpo.2018.04.004

41.

Pew Charitable Trusts. (2010). South Carolina’s Public Safety Reform. http://www.pewtrusts.org/∼/media/assets/2010/06/10/ pspp_south_carolina_brief.pdf

42.

Pew Charitable Trusts. (2016). 33 States Reform Criminal Justice Policies Through Justice Reinvestment”. http://www.pewtrusts.org/en/research-and-analysis/fact-sheets/2016/11/33-states-reform-criminal-justice-policies-through-justice-reinvestment

43.

Pew Charitable Trusts. (2018). More Imprisonment Does Not Reduce State Drug Problems. https://www.pewtrusts.org/en/research-and-analysis/issue-briefs/2018/03/more-imprisonment-does-not-reduce-state-drug-problems

44.

Proctor

S. L.

Herschman

P. L.

(2014). The continuing care model of substance use treatment: What works, and when is “enough,” “enough?”. Psychiatry Journal, 2014(1), 1–16. https://doi.org/10.1155/2014/692423

45.

Rawson

(2017). Vermont Hub-and-Spoke Model of Care for Opioid Use Disorders: An Evaluation. Vermont Center on Behavioral Health. https://www.healthvermont.gov/sites/default/files/documents/pdf/ADAP_Hub_and_Spoke_Evaluation_2017_1.pdf

46.

Reeves

Stuckler

McKee

Gunnell

Chang

S.-S.

Basu

(2012). Increase in state suicide rates in the USA during economic recession. The Lancet, 380(9856), 1813–1814. https://doi.org/10.1016/S0140-6736(12)61910-2

47.

Rouhani

Zhang

Winiker

A. K.

Sherman

S. G.

Bandara

(2024). Emerging models of de facto drug policy reforms in the United States. Drug and Alcohol Dependence, 260, 111341. https://doi.org/10.1016/j.drugalcdep.2024.111341

48.

Rouhani

Weicker

(2023). Evaluation of Prosecutorial Policy Reforms Eliminating Criminal Penalties for Drug Possession and Sex Work in Baltimore, Maryland. https://publichealth.jhu.edu/sites/default/files/2021-10/prosecutorial-policy-evaluation-report-20211019.pdf

49.

Rural Health Information Hub. (2023). Substance Use Disorder Treatment Models. https://www.ruralhealthinfo.org/toolkits/substance-abuse/2/treatment

50.

Saloner

Bandara

S. N.

McGinty

E. E.

Barry

C. L.

(2016). Justice-involved adults with substance use disorders: Coverage increased but rates of treatment did not in 2014. Health Affairs, 35(6), 1058–1066. https://doi.org/10.1377/hlthaff.2016.0005

51.

Selseng

L. B.

Follevåg

B.-M.

Aaslund

(2021). How people with lived experiences of substance use understand and experience user involvement in substance use care: A synthesis of qualitative studies. International Journal of Environmental Research and Public Health, 18(19), 10219. https://doi.org/10.3390/ijerph181910219

52.

Sforza

Saavedra

Schwebke

Basheda

Schauer

Gritchen

et al. (2017). How some Southern California drug rehab centers exploit addiction. Orange County Register. https://www.ocregister.com/2017/05/21/how-some-southern-california-drug-rehab-centers-exploit-addiction/

53.

Sherba

R. T.

Coxe

K. A.

Gersper

B. E.

Linley

J. V.

(2018). Employment services and substance abuse treatment. Journal of Substance Abuse Treatment, 87, 70–78. https://doi.org/10.1016/j.jsat.2018.01.015

54.

Simon

Brothers

Strichartz

Coulter

Voyles

Herdlein

Vincent

(2021). We are the researched, the researchers, and the discounted: The experiences of drug user activists as researchers. The International Journal on Drug Policy, 98, 103364. https://doi.org/10.1016/j.drugpo.2021.103364

55.

Smyth

B. P.

Barry

Keenan

Ducray

(2010). Lapse and relapse following inpatient treatment of opiate dependence. Irish Medical Journal, 103(6), 176–179. https://hdl.handle.net/10147/110022

56.

State of Vermont Blueprint for Health. (2024). Vermont’s Opioid Use Disorder Treatment System. https://blueprintforhealth.vermont.gov/about-blueprint/hub-and-spoke#:∼:text=Medication%20for%20Opioid%20Use%20Disorder%3A%20The%20Evidence%2DBased%20Approach%20to,such%20as%20methadone%20and%20buprenorphine

57.

Sterling

Chi

Hinman

(2011). Integrating care for people with co-occurring alcohol and other drug, medical, and mental health conditions. Alcohol Research & Health, 33(4), 338–349.

58.

Substance Abuse and Mental Health Services Administration. (2009). Supported Employment: Evidence-based Practice Toolkit. [DHHS Publication No. SMA-08-4364]. New Hampshire Dartmouth Psychiatric Research Center and Westat.

59.

Substance Abuse and Mental Health Services Administration. (2020). Medications for Opioid Use Disorder: Treatment Improvement Protocol (Publication No. PEP20-02-01-006. No. 63). Substance Abuse and Mental Health Services Administration.

60.

Substance Abuse and Mental Health Services Administration. (2021a). Substance Use Disorders Recovery with a Focus on Employment and Education (HHS Publication No. PEP21-PL-Guide-6). National Mental Health and Substance Use Policy Laboratory.

61.

Substance Abuse and Mental Health Services Administration. (2021b). Key substance use and mental health indicators in the United States : Results from the 2020 National Survey on Drug Use and Health (HHS Publication No. PEP21-07-01-003, NSDUH Series H-56). Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration. https://www.samhsa.gov/data

62.

Sullivan

M. A.

(2022). Drug use and mental health: Comorbidity between substance use and psychiatric disorders. In Akerele

(Ed.), Substance and non-substance related addictions: A global approach (pp. 3–17). Springer International Publishing. https://doi.org/10.1007/978-3-030-84834-7_1

63.

The National Center on Addiction and Substance Abuse at columbia university. (2012). Five Year National Study Reveals: Addiction Treatment Neglected By U.S. Medical System. https://www.prnewswire.com/news-releases/five-year-national-study-reveals-addiction-treatment-neglected-by-us-medical-system-160333475.html

64.

The White House Executive Office of the President; Office of National Drug Control Policy. (2022). National Drug Control Strategy. https://www.whitehouse.gov/wp-content/uploads/2022/04/National-Drug-Control-2022Strategy.pdf

65.

Tzemis

Buxton

J. A.

(2012). Engaging people who use drugs in policy and program development: A review of the literature. Substance Abuse Treatment, Prevention, and Policy, 7(1), 47. https://doi.org/10.1186/1747-597X-7-47

66.

Torrens

Martin-Santos

Samet

(2006). Importance of clinical diagnoses for comorbidity studies in substance use disorders. Neurotoxicity Research, 10(3–4), 253–261. https://doi.org/10.1007/BF03033361

67.

U.S. Department of Health and Human Services, Health Resources and Services Administration. (2018). National Center for Health Workforce Analysis. State-Level Projections of Supply and Demand for Behavioral Health Occupations: 2016-2030. https://bhw.hrsa.gov/sites/default/files/bureau-healthworkforce/data-research/state-level-estimates-report-2018.pdf

68.

U.S. Department of Health and Human Services, Health Resources and Services Administration. (2020). Behavioral health workforce projections, 2017-2030: HRSA health workforce factsheet . https://bhw.hrsa.gov/sites/default/files/bureau-health-workforce/data-research/bh-workforce-projectionsfact-sheet.pdf

69.

U.S. Department of Labor. (n.d.). Recovery-Ready Workplace. Employment and Training Administration. https://www.dol.gov/agencies/eta/RRW-hub/Recovery-ready-workplace

70.

Wakeman

S. E.

Larochelle

M. R.

Ameli

Chaisson

C. E.

McPheeters

J. T.

Crown

W. H.

Azocar

Sanghavi

D. M.

(2020). Comparative effectiveness of different treatment pathways for opioid use disorder. JAMA Network Open, 3(2), e1920622. https://doi.org/10.1001/jamanetworkopen.2019.20622

71.

White

W. L.

Kelly

J. F.

(2010). Recovery management: What if we really believed that addiction was a chronic disorder? In Kelly

J. F.

White

W. L.

(Eds.), Addiction recovery management (pp. 67–84). Humana Press. https://doi.org/10.1007/978-1-60327-960-4_5